Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research, explains how technology identifies at ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle Cespedes, M.D., M.S., professor of medicine, Icahn School of Medicine at Mount ...

Research might produce treatments of involving transplants with a few, selected types of bacteria tailored to an individual's ...

One of two new studies found most patients doing well six years after treatment. Another study found blood cancers in 17% of ...

After expansion of Medicaid, there was a significant decrease in the low-income population with no healthcare coverage.

Even people living with HIV who have undetectable viral loads experience elevated inflammation levels, explained Michelle Cespedes, M.D., M.S, of Mount Sinai Health System.

Building relationships with state and local officials and repairing the tattered primary care system in the U.S. were some of ...

Before the fungal meningitis outbreak last year related to cosmetic surgery in Mexico, “I hadn’t fully appreciated the vast ...

The survey also found that flexible and virtual appointments, as well as transportation support, were helpful while on ...

Large PBMs are removing Humira from some of their formularies. AMCP Nexus panelists still see challenges and a need for ...